Cancer Chemotherapy Reviews Indexed in
EMBASE/Excerpta Medica
Thursday, July 27, 2017 
ISSN: 2339-8728
 
Subscribers area
Home Editorial Board Journal Contents Subscriptions Contact Us Authors Instructions
     
   
<<< back |


Goal 3: Controlling Tumor Growth and Preserving Quality of Life

2016, Volume 11, Number 5
Javier Martín-Broto
Virgen del Rocío University Hospital; Molecular Oncology and New Therapies Group Oncohematology and Genetics Department Instituto de Biomedicina de Sevilla, Seville, Spain
 

Soft tissue sarcomas (STS) are aggressive neoplasms presenting a five-year survival rate between 55 and 65%, and with approximately 40-50% of patients developing metastatic disease.

 
 
Key words:
 
[Buy Article]
 
 
     
Mallorca, 310 - 08037 Barcelona - Spain
Phone: +34 93 207 59 20
Fax: +34 93 457 66 42
© Permanyer Publications | Made & Powered by IMMA PUIG | Privacy Policy - Legal notice